Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP 501 vs Adalimumab in Rheumatoid Arthritis
NCT01970475Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Amgen. Started Oct 2013; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01970475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01970475.